Brief: Wellnex Life Sees Revenue And Margin Growth To Continue In 2H FY25
Feb 28 (Reuters) - Wellnex Life Ltd WNX.AX: REVENUE AND MARGIN GROWTH EXPECTED TO CONTINUE IN 2H FY25 LEVEL OF TRADE SPEND FOR 2H FY25 WILL REDUCE AS PERCENTAGE OF REVENUE AS WILL OPERATIONAL EXPENSES TARGET OF ACHIEVING POSITIVE EBITDA IN H2 FY25 Further company coverage: WNX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wellnex Life
See all newsWellnex Life Limited - Director’s dealing
Wellnex Life Limited - Completion and Settlement of Sale of Pain Away
Wellnex Life Limited - Change of Chief Financial Officer
Wellnex Life Limited - Annual Report for Year Ended 30 June 2026
Wellnex Life Limited - Posting of EGM Notice and Explanatory Memorandum